Cagrilintide
Cagrilintide is a long-acting analogue of amylin.
Snapshot
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Cagrilintide is a long-acting analogue of amylin. It is being tested to treat obesity and type 2 diabetes by itself and in combination with semaglutide as cagrilintide/semaglutide ("CagriSema").
Text derived from https://en.wikipedia.org/w/index.php?oldid=1361688293 under CC BY-SA 4.0; modifications have been made.